Joanne McDermid

Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study

Clive Ballard, Carol Banister, Zunera Khan et al. · The Lancet Neurology · 2018 · 187 citations

Disease Psychosis, Alzheimer's Disease, Psychiatry +11

Barriers and facilitators to implementing dementia care mapping in care homes: results from the DCM™ EPIC trial process evaluation

Alys Wyn Griffiths, Rachael Kelley, Lucy Garrod et al. · BMC Geriatrics · 2019 · 49 citations · Full text

Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCT

Claire Surr, Ivana Holloway, Rebecca Walwyn et al. · Health Technology Assessment · 2020 · 45 citations · Full text

Collecting self-report research data with people with dementia within care home clinical trials: Benefits, challenges and best practice

Devon Perfect, Alys Wyn Griffiths, Miguel Vasconcelos Da Silva et al. · Dementia · 2019 · 31 citations · Full text

Successful Data Collection, Family Medicine, Geriatric Medicine +17

Impact of the Covid‐19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings

Joanne McDermid, Clive Ballard, Zunera Khan et al. · International Journal of Geriatric Psychiatry · 2023 · 31 citations · Full text